GT BIOPHARMA, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
GT BIOPHARMA, INC. (GTBP) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 28.16 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-28
- GT BIOPHARMA, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 34.79M shares, a 644.15% increase year-over-year.
- GT BIOPHARMA, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 31.38M shares, a 595.27% increase year-over-year.
- GT BIOPHARMA, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 33.52M shares, a 692.46% increase year-over-year.
- GT BIOPHARMA, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 16.24M shares, a 293.96% increase year-over-year.
- GT BIOPHARMA, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 28.16M shares, a 542.06% increase from fiscal 2020.
- GT BIOPHARMA, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 4.39M shares.
- GT BIOPHARMA, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2016 was 24.43M shares, a 920.15% increase from fiscal 2015.
- GT BIOPHARMA, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2015 was 2.39M shares, a 2.86% increase from fiscal 2014.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | 34.79M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | 33.08M shares derived: average of 2 quarters · filed 2022-03-28 | 33.23M shares derived: average of 3 quarters · filed 2022-03-28 | 28.16M shares 10-K · filed 2022-03-28 | ||||
| 2021-09-30 | 31.38M shares 10-Q · filed 2021-11-10 | 32.45M shares derived: average of 2 quarters · filed 2021-12-29 | 25.95M shares 10-Q · filed 2021-11-10 | 21.45M shares derived: average of 4 quarters · filed 2022-03-28 | ||||
| 2021-06-30 | 33.52M shares 10-Q/A · filed 2021-12-29 | 24.93M shares 10-Q/A · filed 2021-12-29 | 18.14M shares derived: average of 3 quarters · filed 2022-03-28 | 14.74M shares derived: average of 4 quarters · filed 2022-03-28 | ||||
| 2021-03-31 | 16.24M shares 10-Q · filed 2021-05-17 | 10.46M shares derived: average of 2 quarters · filed 2022-03-28 | 8.48M shares derived: average of 3 quarters · filed 2022-03-28 | 7.41M shares derived: average of 4 quarters · filed 2022-03-28 | ||||
| 2020-12-31 | 4.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | 4.59M shares derived: average of 2 quarters · filed 2022-03-28 | 4.47M shares derived: average of 3 quarters · filed 2022-03-28 | 4.39M shares 10-K · filed 2022-03-28 | ||||
| 2020-09-30 | 4.51M shares 10-Q · filed 2021-11-10 | 76.73M shares 10-Q · filed 2020-11-13 | 4.37M shares derived: average of 2 quarters · filed 2021-12-29 | 4.29M shares 10-Q · filed 2021-11-10 | 72.91M shares 10-Q · filed 2020-11-13 | |||
| 2020-06-30 | 4.23M shares 10-Q/A · filed 2021-12-29 | 71.90M shares 10-Q · filed 2020-08-14 | 4.18M shares 10-Q/A · filed 2021-12-29 | 70.98M shares 10-Q · filed 2020-08-14 | ||||
| 2020-03-31 | 4.12M shares 10-Q · filed 2021-05-17 | |||||||
| 2019-09-30 | 58.81M shares 10-Q · filed 2020-11-13 | 55.36M shares derived: average of 2 quarters · filed 2020-11-13 | 53.97M shares 10-Q · filed 2020-11-13 | |||||
| 2019-06-30 | 51.92M shares 10-Q/A · filed 2020-08-18 | 51.51M shares 10-Q/A · filed 2020-08-18 | ||||||
| 2018-09-30 | 50.15M shares 10-Q · filed 2019-11-14 | 50.14M shares derived: average of 2 quarters · filed 2019-11-14 | 50.13M shares 10-Q · filed 2019-11-14 | |||||
| 2018-06-30 | 50.12M shares 10-Q · filed 2019-08-14 | 50.12M shares 10-Q · filed 2019-08-14 | ||||||
| 2016-12-31 | 24.43M shares 10-K · filed 2017-03-31 | |||||||
| 2015-12-31 | 2.39M shares 10-K/A · filed 2018-02-28 | |||||||
| 2014-12-31 | 2.33M shares 10-K/A · filed 2018-02-28 | 581.97M shares 10-K · filed 2015-03-31 | ||||||
| 2013-12-31 | 572.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | 572.96M shares derived: average of 2 quarters · filed 2015-03-31 | 566.63M shares 10-K · filed 2015-03-31 | |||||
| 2013-09-30 | 573.05M shares 10-Q · filed 2014-12-17 | 564.54M shares 10-Q · filed 2014-12-17 | ||||||
| 2012-12-31 | 476.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-08 | 436.99M shares derived: average of 2 quarters · filed 2015-01-08 | 401.08M shares derived: average of 3 quarters · filed 2015-01-08 | 371.72M shares 10-K · filed 2015-01-08 | ||||
| 2012-09-30 | 397.55M shares 10-Q · filed 2014-12-17 | 363.41M shares derived: average of 2 quarters · filed 2014-12-17 | 336.82M shares 10-Q · filed 2014-12-17 | |||||
| 2012-06-30 | 329.27M shares 10-Q/A · filed 2012-09-13 | 306.13M shares 10-Q/A · filed 2012-09-13 | ||||||
| 2011-12-31 | 255.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-18 | 234.40M shares derived: average of 2 quarters · filed 2014-11-18 | 217.06M shares derived: average of 3 quarters · filed 2014-11-18 | 201.10M shares 10-K · filed 2014-11-18 | ||||
| 2011-09-30 | 213.51M shares 10-Q · filed 2012-11-21 | 197.94M shares derived: average of 2 quarters · filed 2012-11-21 | 183.04M shares 10-Q · filed 2012-11-21 | |||||
| 2011-06-30 | 182.37M shares 10-Q/A · filed 2012-09-13 | 167.55M shares 10-Q/A · filed 2012-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |